Ideas

Anticancer therapy: MiRNA-9600 increases the expression of DNA repair protein hMSH2 and inhibits cancer development via down regulation of its target gene, 25/November/2015, 11.56 am

Anticancer therapy: MiRNA-9600 increases the expression of DNA repair protein hMSH2 and inhibits cancer development via down regulation of its target gene, 25/November/2015, 11.56 am 150 150 Dr Boomi's Genom-2-Discovery Center

Research findings to Therapeutic opportunity:  The study presented here suggests that MiRNA-9600, by decreasing the expression of its target genes, it may increase the expression of DNA repair protein hMSH2. [easy_payment currency=”USD”]…

read more

Natural product therapy for glucose homeostasis and TIIDM: Methyl 3,5-dicaffeoyl quinate (MDQ), a flavonoid glucoside found in Castor-aralia (kalopanax-pictus), Salicornia herbacea L., Aster oharai and Solidago virga-aurea var. gigantean, increases IKKß and XBP1s activity, decreases the levels of tumor suppressor/stress-responsive proteins, such as PDCD4, and PTEN, reduces ER stress, improves insulin sensitivity, promotes glucose homeostasis and prevents the progression of TIIDM via up regulation of its target gene, 25/November/2015, 10.54 am

Natural product therapy for glucose homeostasis and TIIDM: Methyl 3,5-dicaffeoyl quinate (MDQ), a flavonoid glucoside found in Castor-aralia (kalopanax-pictus), Salicornia herbacea L., Aster oharai and Solidago virga-aurea var. gigantean, increases IKKß and XBP1s activity, decreases the levels of tumor suppressor/stress-responsive proteins, such as PDCD4, and PTEN, reduces ER stress, improves insulin sensitivity, promotes glucose homeostasis and prevents the progression of TIIDM via up regulation of its target gene, 25/November/2015, 10.54 am 150 150 Dr Boomi's Genom-2-Discovery Center

What they say:  A study from the Division of Endocrinology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02130, USA; Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology,…

read more

Anti-telomerase cancer therapy: MiRNA-340 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down-regulation of its target gene, 25/November/2016, 7.45 am

Anti-telomerase cancer therapy: MiRNA-340 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down-regulation of its target gene, 25/November/2016, 7.45 am 150 150 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:   The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; and I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and…

read more

Natural product Life-extension therapy: Boehmenan, found in stem of Caulis clematidis armandii and Hibiscus ficulneus, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 25/November/2016, 6.55 am

Natural product Life-extension therapy: Boehmenan, found in stem of Caulis clematidis armandii and Hibiscus ficulneus, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 25/November/2016, 6.55 am 150 150 Dr Boomi's Genom-2-Discovery Center

What they say? A recent study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase…

read more

Anti-metastasis therapy: MiRNA-9600 increases the expression of metastasis suppressor Sprouty2 and inhibits proliferation, invasion and metastasis of cancer cells via down regulation of its target gene,24/November/2015, 3.38 pm

Anti-metastasis therapy: MiRNA-9600 increases the expression of metastasis suppressor Sprouty2 and inhibits proliferation, invasion and metastasis of cancer cells via down regulation of its target gene,24/November/2015, 3.38 pm 150 150 Dr Boomi's Genom-2-Discovery Center

Research findings to Therapeutic opportunity:  The study presented here suggests that MiRNA-9600, by decreasing the expression of its target genes, it may increase the expression of metastasis suppressor Sprouty2. Thereby, it may…

read more

MiRNA-based PD-1 pathway blockade for Human cancer therapy: MiR-1976 inhibits the expression of co-inhibitory receptor PD-1 on Antigen- Specific T-cells, increases the production of cytokines by tumor-infiltrating lymphocytes (TIL), and draining lymph nodes and augments anti-tumor activity via down-regulation of its target gene, 24/November/2016, 3.33 pm

MiRNA-based PD-1 pathway blockade for Human cancer therapy: MiR-1976 inhibits the expression of co-inhibitory receptor PD-1 on Antigen- Specific T-cells, increases the production of cytokines by tumor-infiltrating lymphocytes (TIL), and draining lymph nodes and augments anti-tumor activity via down-regulation of its target gene, 24/November/2016, 3.33 pm 150 150 Dr Boomi's Genom-2-Discovery Center

Introduction:What they say:  A recent study from Division of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD 21218, United States shows that “TGF-β1-Mediated Smad3 Enhances PD-1 Expression on…

read more